Active Ingredient(s):Lonapegsomatropin-tcgd FDA Approved: * August 25, 2021 Pharm Company: *ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S Category:Growth Hormone Treatment
Lonapegsomatropin, sold under the brand name Skytrofa, is a human growth hormone used for the treatment of growth hormone deficiency. Lonapegsomatropin is a prodrug of somatropin.
Lonapegsomatropin was approved for medical use in the United States in August 2021.
1 Medical uses
3 Further reading
4 External links
Lonapegsomatropin is a growth hormone therapy ...
* May have multiple approval dates, manufacturers, or labelers.
Skytrofa 3 mg Subcutaneous Injection, Powder, Lyophilized, for Solution